Publications by authors named "Jason Ruth"

Claim this Profile
A
Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy.
Samantha Dwyer, Jason Ruth, Hans E Seidel, Amelie A Raz, Lewis A Chodosh

Breast Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Sheila K Pierson, Sushila Shenoy, Ana B Oromendia, Alexander M Gorzewski, Ruth-Anne Langan Pai, Jason R Ruth

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dormancy in minimal residual disease following targeted therapy.
Jason R Ruth, Dhruv K Pant, Tien-Chi Pan, Hans E Seidel, Sanjeethan C Baksh

Breast Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder.
Sheila K Pierson, Johnson S Khor, Jasira Ziglar, Amy Liu, Katherine Floess, Jason Ruth

Cell Rep Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Christopher S Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R Ruth

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.
David C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, Helen L Partridge, Sheila K Pierson, Jason R Ruth

J Clin Invest· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Frits van Rhee, Peter Voorhees, Angela Dispenzieri, Alexander Fosså, Gordan Srkalovic, Jason Ruth

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease.
Sheila K Pierson, Aaron J Stonestrom, Dustin Shilling, Jason Ruth, Christopher S Nabel

Am J Hematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
David C Fajgenbaum, Thomas S Uldrick, Adam Bagg, Dale Frank, David Wu, Jason Ruth

Blood· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research.
David C Fajgenbaum, Jason R Ruth, Dermot Kelleher, Arthur H Rubenstein

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic multicentric Castleman's disease: a systematic literature review.
Amy Y Liu, Christopher S Nabel, Brian S Finkelman, Jason R Ruth, Razelle Kurzrock

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Gregory V Kryukov, Frederick H Wilson, Jason R Ruth, Joshiawa Paulk, Aviad Tsherniak

Science· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research.
Samantha Kass Newman, Raj K Jayanthan, Grant W Mitchell, Jossie A Carreras Tartak, Michael P Croglio, Jason R Ruth

Yale J Biol Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.
Yi Feng, Tien-Chi Pan, Dhruv K Pant, Kristi R Chakrabarti, James V Alvarez, Jason R Ruth

Cancer Discov· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.
James V Alvarez, Tien-Chi Pan, Jason Ruth, Yi Feng, Alice Zhou

Cancer Cell· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments.
Mark A LaBarge, Celeste M Nelson, Rene Villadsen, Agla Fridriksdottir, Jason R Ruth

Integr Biol (Camb)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis